Optimizing Care of Patients Via Telehealth In Monitoring and Augmenting Their Control of Diabetes Mellitus
NCT04306770 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330
Last updated 2020-03-13
Summary
OPTIMUM study aims to use the telehealth-enabled chronic disease management programme for individuals with chronic diseases to provide timely intervention to prevent disease deterioration, increase compliance to treatment regimen (e.g. medication), and most importantly, engage participants to better manage their own care.
Conditions
Interventions
- OTHER
-
OPTIMUM programme
OPTIMUM programme encompass of telehealth service to support the patient. Study participants will be given devices (Bluetooth-enabled blood pressure machine, weighing scale and glucometer) to monitor their parameters at home. Care team will use the Phillips "Vital Health" to perform tele-monitoring, tele-management (individualized on-line health coaching and timely interventions), and to deliver education content.
Sponsors & Collaborators
-
MOH Office for Healthcare Transformation (MOHT), Singapore
collaborator UNKNOWN -
Phillips Healthcare, Singapore
collaborator UNKNOWN -
Reinsurance Group of America (RGA), Singapore
collaborator UNKNOWN -
SingHealth Polyclinics
lead OTHER
Principal Investigators
-
Ngiap Chuan Tan, FCFPS · SingHealth Polyclinics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 26 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-01-20
- Primary Completion
- 2022-07-01
- Completion
- 2022-07-01
Countries
- Singapore
Study Locations
More Related Trials
-
Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus
NCT01545024 ·Status: UNKNOWN
-
A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
NCT01709305 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes
NCT03817463 ·Status: COMPLETED
-
Effects of DPP4 Inhibition on COVID-19
NCT04341935 ·Status: WITHDRAWN ·Phase: PHASE4
-
DPP4 Inhibitor on Glycemic Variability
NCT04654676 ·Status: COMPLETED ·Phase: PHASE4
-
Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
NCT01766778 ·Status: COMPLETED ·Phase: PHASE4
-
Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients
NCT03071016 ·Status: COMPLETED
-
Polypill Versus Metformin in New Onset Type 2 Diabetes
NCT05833958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
NCT02301806 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
NCT01703637 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
NCT01984606 ·Status: WITHDRAWN ·Phase: PHASE3
-
Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM
NCT04267601 ·Status: UNKNOWN
-
IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics
NCT04982705 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
NCT02754817 ·Status: COMPLETED
-
Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery
NCT04340908 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Sitagliptin in Glycemic Control in Real World
NCT01316835 ·Status: UNKNOWN
-
Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
NCT02324010 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
NCT01341717 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes
NCT01933672 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
NCT05971940 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION)
NCT01541956 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Empagliflozin on Body Composition and Ketones
NCT03877406 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
NCT01660386 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
NCT01289990 ·Status: COMPLETED ·Phase: PHASE3
-
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
NCT05768945 ·Status: COMPLETED